microdosing glp-1 for menopause Perimenopause and Menopause: A Hormone-Aware Metabolic Framework Jill - More and more
Description
Approved by the FDA for type 2 diabetes management (as Ozempic and Rybelsus) and chronic weight management (as Wegovy), semaglutide represents a significant advancement in GLP-1-based therapeutics
As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide mimics the action of the GLP-1 hormone in the body
Generally, the amount of thinking about food or food cue reactivity has been reduced (Hayashi et al., 2023)
Download our Free Peptide Guide and get the basics, the buzz, and the must-knows all in one place
